SCHEMBL6276873

SCHEMBL6276873

CCCCCCCCOc1c(O)c2ccc(OCCCC(=O)O)cc2oc1=O

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH2 P05091 9/20 0.53
▸ MAOA P21397 8/20 0.53
▸ MAOB P27338 8/20 0.53
▸ MAP1LC3B Q9GZQ8 1/20 0.48
▸ MAP1LC3A Q9H492 1/20 0.48
▸ PLA2G4B P0C869 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ RAB9A P51151 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ TSHR P16473 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ ACSL1 P33121 2/20 0.47
▸ ACSL6 Q9UKU0 2/20 0.47
▸ HDAC1 Q13547 1/20 0.46
▸ GPR17 Q13304 1/20 0.46
▸ NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6270807 1.00 ALDH2 (0.53) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL6275338 0.98 ALDH2 (0.56) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL27439384 0.98 ALDH2 (0.56) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL6277088 0.98 ALDH2 (0.56) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL27440430 0.98 ALDH2 (0.56) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL27443884 0.97 ALDH2 (0.57) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL6276032 0.97 MAOA (0.51) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL6270780 0.96 ALDH2 (0.51) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL6276248 0.96 ALDH2 (0.51) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A
SCHEMBL6276076 0.96 ALDH2 (0.55) ALDH2MAOAMAOBMAP1LC3BMAP1LC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 ALDH2 590/4885MAOA 665/4885MAOB 1155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback